A 28-year-old female was involved in a motor vehicle collision 4 days ago. She sustained a fractured left arm and multiple contusions. She was hospitalized for 2 days and discharged with analgesics and orthopedic follow-up. Since discharge, she reports recurrent nightmares about the crash, flashbacks triggered by car sounds, and intense anxiety when riding in vehicles. She has begun avoiding driving and refuses to travel by car. She reports difficulty sleeping and feels emotionally numb. Her symptoms began immediately after the accident. Which of the following is the most appropriate initial pharmacological intervention?

Explanation

## Pharmacological Management of Acute Stress Disorder / Early PTSD ### Clinical Context This patient is **4 days post-trauma** with: - Intrusive nightmares and flashbacks (re-experiencing) - Avoidance of trauma-related cues (vehicles, driving) - Hyperarousal (insomnia, anxiety) - Emotional numbing - Symptom onset immediately after trauma This presentation is consistent with **Acute Stress Disorder** (symptoms within 3 days to 1 month post-trauma). ### Pharmacological Approach in Acute Stress Disorder **Key Point:** The first-line pharmacological approach for Acute Stress Disorder and early PTSD is **selective serotonin reuptake inhibitors (SSRIs)**, specifically **sertraline** or **paroxetine**, which are FDA-approved for PTSD. ### Evidence-Based Pharmacotherapy Comparison | Agent Class | Drug | Indication | Evidence | Timing | |-------------|------|-----------|----------|--------| | **SSRI** | Sertraline, Paroxetine | First-line for PTSD/ASD | FDA-approved, strong RCT evidence | Can start acutely | | **Alpha-1 blocker** | Prazosin | Nightmare-specific PTSD | Effective for nightmares, not acute phase | Weeks 2–4+ | | **Beta-blocker** | Propranolol | Adjunctive (limited evidence) | Weak evidence, not first-line | Not recommended acutely | | **Benzodiazepine** | Alprazolam | NOT recommended | Risk of dependence, may impair trauma processing | Avoid in acute phase | ### Why Sertraline Is Optimal 1. **FDA-Approved Status:** Sertraline and paroxetine are the only SSRIs with FDA approval for PTSD treatment. 2. **Mechanism:** Increases serotonergic neurotransmission, reducing hyperarousal and improving mood regulation. 3. **Timing:** Can be initiated acutely (within days of trauma) without contraindication. 4. **Efficacy:** Reduces re-experiencing, avoidance, hyperarousal, and negative mood symptoms. 5. **Safety Profile:** Well-tolerated with minimal acute side effects; no risk of dependence. **High-Yield:** Sertraline 50 mg daily is the standard starting dose for PTSD; titrate to 200 mg daily over 4–6 weeks based on response. ### Why Other Options Are Suboptimal **Clinical Pearl:** Benzodiazepines (like alprazolam) are **contraindicated in acute PTSD** because they: - May impair fear extinction and trauma processing - Carry high risk of dependence and abuse - Do not address core PTSD pathology - Can worsen long-term outcomes **Prazosin** is highly effective for **nightmare-specific PTSD** but is typically introduced **after 2–4 weeks** of SSRI therapy, not as initial monotherapy in the acute phase. **Propranolol** has weak evidence and is not recommended as monotherapy for PTSD; it may reduce some peripheral anxiety symptoms but does not address core re-experiencing and avoidance. ### Treatment Algorithm for Acute Stress Disorder ```mermaid flowchart TD A[Acute Stress Disorder<br/>Days 1-30 post-trauma]:::outcome --> B[Psychotherapy first-line:<br/>Trauma-focused CBT, EMDR]:::action A --> C{Severe symptoms or<br/>functional impairment?}:::decision C -->|Yes| D[Add SSRI:<br/>Sertraline 50 mg daily]:::action C -->|No| E[Monitor, psychotherapy alone]:::action D --> F[Titrate to 200 mg over<br/>4-6 weeks]:::action F --> G{Nightmare-specific<br/>symptoms persist?}:::decision G -->|Yes| H[Add Prazosin 1 mg<br/>at bedtime]:::action G -->|No| I[Continue SSRI monotherapy]:::action J[AVOID:<br/>Benzodiazepines]:::urgent ``` ### Mnemonic: PTSD Pharmacotherapy **SPAR:** - **S** = SSRI (Sertraline/Paroxetine) — first-line - **P** = Prazosin — for nightmares (add-on, later phase) - **A** = Avoid benzodiazepines - **R** = Refer for trauma-focused psychotherapy (gold standard)